SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 19, 2003
IntraBiotics Pharmaceuticals, Inc.
Delaware
(State or other jurisdiction of incorporation)
| 0-29993 | 94-3200380 | |
| (Commission File No.) | (IRS Employer Identification No.) |
2483 East Bayshore Road, Suite 100
Palo Alto, California 94303
(Address of principal executive offices and zip code)
Registrant’s telephone number, including area code: (650) 526-6800
| Item 5. Other Events and Regulation FD Disclosure | ||||||||
| Item 7. Financial Statements, Pro Forma Financial Information and Exhibits | ||||||||
| SIGNATURE | ||||||||
| INDEX TO EXHIBITS | ||||||||
| EXHIBIT 99.1 | ||||||||
Item 5. Other Events and Regulation FD Disclosure
On September 19, 2003, IntraBiotics Pharmaceuticals, Inc. issued a press release entitled, “IntraBiotics Reaches Special Protocol Assessment (SPA) Agreement with FDA”. This press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits.
| 99.1 | Press Release, dated September 19, 2003, entitled “IntraBiotics Reaches Special Protocol Assessment (SPA) Agreement with FDA.” |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| INTRABIOTICS PHARMACEUTICALS, INC. | ||||
| Dated: September 23, 2003 | ||||
| By: | /s/ Eric Bjerkholt | |||
| Eric H. Bjerkholt Sr. Vice President and Chief Financial Officer |
||||
INDEX TO EXHIBITS
| 99.1 | Press Release, dated September 19, 2003, entitled “IntraBiotics Reaches Special Protocol Assessment (SPA) Agreement with FDA.” |